Corneal Neovascularization: From Pathogenesis to Therapeutic Strategies
Journal of Clinical & Translational Ophthalmology · 03.11.2026 · 4 (4) · 28
DOI: 10.3390/jcto4040028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Translational Ophthalmology, online erschienen am 03.11.2026. Verfasst von Basanta Bhujel und 4 weiteren Autor:innen. Die Arbeit nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences.
Abstract (Originalsprache)
Corneal neovascularization is a pathological response to corneal injury and inflammation characterized by the abnormal growth of blood vessels into the normally avascular cornea, resulting in corneal opacity, scarring, lipid deposition, and impaired visual function. Its development is driven by a complex imbalance between pro- and anti-angiogenic factors and is closely associated with inflammatory responses, immune activation, and tissue remodelling. Despite advances in understanding these mechanisms and the availability of various treatments, effective management of persistent and established corneal neovascularization remains challenging, particularly because existing therapies may provide incomplete or temporary vascular regression. This review provides an overview of the molecular and cellular mechanisms underlying corneal neovascularization and critically evaluates established therapeutic approaches, as well as emerging molecular and adjuvant therapies. Emphasis is placed on their therapeutic potential, current limitations, and the challenges of achieving effective and sustained vascular regression. Finally, future perspectives are discussed, highlighting the need for more targeted and durable therapeutic approaches that address the multifaceted mechanisms underlying pathological corneal neovascularization. A deeper understanding of these mechanisms may facilitate the development of more effective treatments and ultimately contribute to improved corneal transparency and visual outcomes.
Förderung
- National Research Foundation of Korea
- Asan Institute for Life Sciences
Zitieren
APA
Bhujel, B., Eah, K. S., Kang, S. S., Chung, H. S., & Kim, J. (2026). Corneal Neovascularization: From Pathogenesis to Therapeutic Strategies. Journal of Clinical & Translational Ophthalmology, 4(4), 28. https://doi.org/10.3390/jcto4040028
Vancouver
Bhujel B, Eah KS, Kang SS, Chung HS, Kim J. Corneal Neovascularization: From Pathogenesis to Therapeutic Strategies. Journal of Clinical & Translational Ophthalmology. 2026;4(4):28. doi:10.3390/jcto4040028
BibTeX
@article{Bhujel2026,
author = {Bhujel, Basanta and Eah, Kyu Sang and Kang, Soon Suk and Chung, Ho Seok and Kim, Jae-Yong},
title = {Corneal Neovascularization: From Pathogenesis to Therapeutic Strategies},
journal = {Journal of Clinical & Translational Ophthalmology},
year = {2026},
volume = {4},
number = {4},
pages = {28},
doi = {10.3390/jcto4040028}
}
EUVIMED